February 5, 2021
Johnson and Johnson requests emergency approval for coronavirus vaccine
Johnson & Johnson requested emergency use authorization from the FDA for its single-dose coronavirus vaccine yesterday. The vaccine was found to be 66% effective overall in late-stage clinical trials (including 72% in the US and 57% in South Africa).
